Nootropics Market Analysis, On-Going Trends, Status, Forecast 2027

1. NootropicsMarket To Reach USD 5.32 Billion By 2026 www.reportsanddata.com

2. MarketSummary According to the current analysis of Reports and Data, the global nootropics marketwas valued at USD 1.96 billion in 2018 and is expected to reach USD 5.32 billion by the year 2026, at a CAGR of 13.2%. Nootropics are compounds that enhance the cognitive performance of an individual. These substance, also known as smart drugs, are a class of ingredients which can boost the memory, enhance creativity levels, decision making capabilities and improve brain performance. Nootropics medication are of two types, prescription and nonprescription. Prescription medication gives stimulant effects, counteracting the symptoms of medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy while nonprescription medications are used to boost mental performance due to their cholinergicmechanisms. The market for these substances is anticipated to get augmented by factors such as the increasing demand for brain boosters owing to the competitive work environment across various domains, rising demand from the sports industry for brain and improved decision making, and the growing awareness regarding mentalillnesses. However, the side effects associated with regular consumption of these pills, lack of awareness among consumers regarding these products, addiction to the drug and hesitation among people to visit psychiatrists or neurologists in emerging countries would impede the growth of thismarket. www.reportsanddata.com

3. Further key findings from the reportsuggest • The application type segment is dominated by the memory enhancement type nootropics owing to the challenging work environment demanding potential employees. It is anticipated to grow at a CAGR of 13.7 % during the forecast period. • HVMN, a U.S. based manufacturer and seller of ketone associated products launched HVMN Ketone at thebeginning • of 2018, which is claimed to enhance both physical and cognitiveperformance. • In recent years, consumer have shifted to organic nootropics as well such as coffee, matcha tea, green tea, kucha tea, spinach, beets, peanuts, eggs, liver, brahmi, arctic root, turmeric, ginseng, pine bark, and fishoil. • According to the American Exercise Council (ACE), around 50% of the consumers in the U.S. prefer to buy natural ingredient products. The growth in vegan population is expected to drive demand for natural products in developed regions such as Europe and NorthAmerica. • Manufacturers for Nootropics are focused on natural ingredients to satisfy the growing demand. For instance, Gaia Herbs launched a new product in April 2019 called Bacopa a vegan supplement made using natural ingredient. It contains lemon balm, saffron andspearmint. • North America remains the key revenue generating geographical segment in this market. The geographical segment accounted for USD 740.1 million in 2018. Availability presence of key market players in the region, rising focus on precision medicine, and rising awareness about nootropics applications, are among the key factors driving the market growth for Nootropics in thisregion • The global Nootropics market is highly fragmented with major players like Accelerated Intelligence Inc., AlternaScript; HVMN, Onnit Labs, Inc., Peak Nootropics, Teva Pharmaceutical Industries, Purelife bioscience Co., Ltd., United Pharmacies, SupNootropic bio co., Ltd., and Powder City collectively constituting a competitivemarket. www.reportsanddata.com

4. For the purpose of this report, Reports and Data has segmented the Nootropics market on the basis of drugs type, application, distribution channel andregion: Drug Type Outlook (Revenue in Million USD;2016–2026) Prescription Nootropics Modafinil (Provigil) Adderall Methylphenidate (Ritalin) Memantine (Axura) OTCNootropics Ginkgo Biloba Panax Ginseng RhodiolaRosea Nicotine Caffeine Racetams Piracetam Pramiracetam Phenylpiracetam Aniracetam www.reportsanddata.com

5. Application Outlook (Revenue in Million USD;2016–2026) MemoryEnhancement Mood & Depression Attention & Focus Longevity & Anti-aging Sleep & Recovery Anxiety Distribution Channel Outlook (Revenue in Million USD;2016–2026) Offline Online Read full Report Description @ https://www.reportsanddata.com/report- detail/nootropics-market Regional Outlook (Revenue in Million USD;2016–2026) NorthAmerica Europe AsiaPacific Middle East &Africa LatinAmerica www.reportsanddata.com

6. AboutUs Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter businessdecision. ContactUS JohnWatson Head ofBusinessDevelopment Reports And Data|Web: www.reportsanddata.com Direct Line:+1-212-710-1370 E-mail:sales@reportsanddata.com We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. www.reportsanddata.com